1. Home
  2. ENLV

ENLV

Enlivex Therapeutics Ltd.

Logo Enlivex Therapeutics Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-23-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Founded: 2005 Country:
N/A
Employees: N/A City: N/A
Market Cap: 24.6M IPO Year: 1995
Target Price: $7.00 AVG Volume (30 days): 173.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.56 EPS Growth: N/A
52 Week Low/High: $1.20 - $4.59 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: